• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤发生、侵袭和转移的遗传及基因组通路

Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis.

作者信息

Motwani Jyoti, Eccles Michael R

机构信息

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Maurice Wilkins Centre for Molecular Biodiscovery, Auckland 1010, New Zealand.

出版信息

Genes (Basel). 2021 Sep 28;12(10):1543. doi: 10.3390/genes12101543.

DOI:10.3390/genes12101543
PMID:34680938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8535311/
Abstract

Melanoma is a serious form of skin cancer that accounts for 80% of skin cancer deaths. Recent studies have suggested that melanoma invasiveness is attributed to phenotype switching, which is a reversible type of cell behaviour with similarities to epithelial to mesenchymal transition. Phenotype switching in melanoma is reported to be independent of genetic alterations, whereas changes in gene transcription, and epigenetic alterations have been associated with invasiveness in melanoma cell lines. Here, we review mutational, transcriptional, and epigenomic alterations that contribute to tumour heterogeneity in melanoma, and their potential to drive melanoma invasion and metastasis. We also discuss three models that are hypothesized to contribute towards aspects of tumour heterogeneity and tumour progression in melanoma, namely the clonal evolution model, the cancer stem cell model, and the phenotype switching model. We discuss the merits and disadvantages of each model in explaining tumour heterogeneity in melanoma, as a precursor to invasion and metastasis.

摘要

黑色素瘤是一种严重的皮肤癌形式,占皮肤癌死亡人数的80%。最近的研究表明,黑色素瘤的侵袭性归因于表型转换,这是一种可逆的细胞行为类型,类似于上皮-间质转化。据报道,黑色素瘤中的表型转换与基因改变无关,而基因转录的变化和表观遗传改变与黑色素瘤细胞系的侵袭性有关。在这里,我们综述了导致黑色素瘤肿瘤异质性的突变、转录和表观基因组改变,以及它们驱动黑色素瘤侵袭和转移的潜力。我们还讨论了三种被假设有助于黑色素瘤肿瘤异质性和肿瘤进展的模型,即克隆进化模型、癌症干细胞模型和表型转换模型。我们讨论了每种模型在解释黑色素瘤肿瘤异质性(作为侵袭和转移的前兆)方面的优缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/b951d9ac6a05/genes-12-01543-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/12f7c84227ab/genes-12-01543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/00ff6d116424/genes-12-01543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/00504c7b863f/genes-12-01543-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/896ab13f7079/genes-12-01543-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/b951d9ac6a05/genes-12-01543-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/12f7c84227ab/genes-12-01543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/00ff6d116424/genes-12-01543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/00504c7b863f/genes-12-01543-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/896ab13f7079/genes-12-01543-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948b/8535311/b951d9ac6a05/genes-12-01543-g005.jpg

相似文献

1
Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis.黑色素瘤发生、侵袭和转移的遗传及基因组通路
Genes (Basel). 2021 Sep 28;12(10):1543. doi: 10.3390/genes12101543.
2
Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.DNA结合抑制因子4(ID4)在人类黑色素瘤组织中高表达,可能发挥限制黑色素瘤细胞正常分化的作用。
PLoS One. 2015 Feb 2;10(2):e0116839. doi: 10.1371/journal.pone.0116839. eCollection 2015.
3
Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.线性黑素瘤进展细胞模型中动态表型转换和新型疾病生物标志物的转录特征。
Neoplasia. 2021 Apr;23(4):439-455. doi: 10.1016/j.neo.2021.03.007. Epub 2021 Apr 9.
4
The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.Wnt/β-连环蛋白信号通路在黑色素瘤上皮-间充质样转变中的作用:来自患者来源细胞系的证据
Oncotarget. 2016 Jul 12;7(28):43295-43314. doi: 10.18632/oncotarget.9232.
5
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.甲基化依赖性SOX9表达介导人黑色素瘤细胞的侵袭,并且是晚期黑色素瘤的不良预后因素。
Genome Biol. 2015 Feb 22;16(1):42. doi: 10.1186/s13059-015-0594-4.
6
NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.NFIB 通过调节 EZH2 和 MITF 介导 BRN2 驱动的黑色素瘤细胞迁移和侵袭。
EBioMedicine. 2017 Feb;16:63-75. doi: 10.1016/j.ebiom.2017.01.013. Epub 2017 Jan 16.
7
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma.单细胞分析解析转移性黑色素瘤中的分子异质性和疾病演进。
Cell Death Dis. 2019 Oct 31;10(11):827. doi: 10.1038/s41419-019-2048-5.
8
Epigenetic regulation in human melanoma: past and future.人类黑色素瘤中的表观遗传调控:过去与未来
Epigenetics. 2015;10(2):103-21. doi: 10.1080/15592294.2014.1003746.
9
Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.配对的原发性和转移性细胞系的全基因组甲基化测序确定了常见的DNA甲基化变化以及EBF3作为黑色素瘤转移候选表观遗传驱动因子的作用。
Oncotarget. 2017 Jan 24;8(4):6085-6101. doi: 10.18632/oncotarget.14042.
10
Heterogeneous tumor subpopulations cooperate to drive invasion.异质性肿瘤亚群协同驱动侵袭。
Cell Rep. 2014 Aug 7;8(3):688-95. doi: 10.1016/j.celrep.2014.06.045. Epub 2014 Jul 24.

引用本文的文献

1
Uncovering Anti-Melanoma Mechanisms of Leaf Compounds via Network Pharmacology and Molecular Docking.通过网络药理学和分子对接揭示叶化合物的抗黑色素瘤机制
Int J Mol Sci. 2025 Jun 25;26(13):6120. doi: 10.3390/ijms26136120.
2
GPNMB marks a quiescent cell population in melanoma and promotes metastasis formation.GPNMB标记黑色素瘤中的静止细胞群并促进转移形成。
EMBO Rep. 2025 Jun 17. doi: 10.1038/s44319-025-00501-w.
3
Investigating therapeutic efficacy of dacarbazine and temozolomide, alone and in combination with siRNA in A375 human melanoma cell line.

本文引用的文献

1
Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy.黑色素瘤可塑性:转移及治疗抵抗的促进因素
Front Oncol. 2021 Sep 16;11:756001. doi: 10.3389/fonc.2021.756001. eCollection 2021.
2
Transcriptional Reprogramming and Constitutive PD-L1 Expression in Melanoma Are Associated with Dedifferentiation and Activation of Interferon and Tumour Necrosis Factor Signalling Pathways.黑色素瘤中的转录重编程和组成性PD-L1表达与去分化以及干扰素和肿瘤坏死因子信号通路的激活相关。
Cancers (Basel). 2021 Aug 24;13(17):4250. doi: 10.3390/cancers13174250.
3
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4.
研究达卡巴嗪和替莫唑胺单独及与小干扰RNA联合应用于A375人黑色素瘤细胞系的治疗效果。
Iran J Basic Med Sci. 2025;28(6):772-783. doi: 10.22038/ijbms.2025.84187.18208.
4
The small molecule ML233 is a direct inhibitor of tyrosinase function.小分子ML233是酪氨酸酶功能的直接抑制剂。
Commun Biol. 2025 Mar 28;8(1):506. doi: 10.1038/s42003-025-07973-5.
5
The small molecule ML233 is a direct inhibitor of tyrosinase function.小分子ML233是酪氨酸酶功能的直接抑制剂。
bioRxiv. 2025 Feb 20:2025.02.16.638443. doi: 10.1101/2025.02.16.638443.
6
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.WT161是一种选择性组蛋白去乙酰化酶6(HDAC6)抑制剂,可抑制黑色素瘤细胞的生长、增强其化学敏感性、促进细胞凋亡并抑制细胞迁移。
Cancer Chemother Pharmacol. 2025 Jan 17;95(1):22. doi: 10.1007/s00280-024-04731-y.
7
An ensemble-based deep learning model for detection of mutation causing cutaneous melanoma.基于集成的深度学习模型用于检测导致皮肤黑色素瘤的突变。
Sci Rep. 2023 Dec 14;13(1):22251. doi: 10.1038/s41598-023-49075-4.
8
Morphological aspects and therapeutic options in melanoma: a narrative review of the past decade.黑色素瘤的形态学特征及治疗选择:对过去十年的回顾性叙述
Rom J Morphol Embryol. 2023 Apr-Jun;64(2):135-141. doi: 10.47162/RJME.64.2.02.
9
Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment.肿瘤微环境作为黑色素瘤治疗的一个治疗靶点。
Cancers (Basel). 2023 Jun 11;15(12):3147. doi: 10.3390/cancers15123147.
10
Correlation Between Endoglin and Malignant Phenotype in Human Melanoma Cells: Analysis of hsa-mir-214 and hsa-mir-370 in Cells and Their Extracellular Vesicles.人黑色素瘤细胞中内皮糖蛋白与恶性表型的相关性:细胞及其细胞外囊泡中hsa-mir-214和hsa-mir-370的分析
Adv Exp Med Biol. 2023;1408:253-272. doi: 10.1007/978-3-031-26163-3_14.
SALL4 通过表观遗传控制黑色素瘤细胞的侵袭性。
Nat Commun. 2021 Aug 20;12(1):5056. doi: 10.1038/s41467-021-25326-8.
4
Single-cell and spatial analyses of cancer cells: toward elucidating the molecular mechanisms of clonal evolution and drug resistance acquisition.癌细胞的单细胞和空间分析:旨在阐明克隆进化和获得耐药性的分子机制
Inflamm Regen. 2021 Jul 16;41(1):22. doi: 10.1186/s41232-021-00170-x.
5
Comparison of Global DNA Methylation Patterns in Human Melanoma Tissues and Their Derivative Cell Lines.人类黑色素瘤组织及其衍生细胞系中全基因组DNA甲基化模式的比较
Cancers (Basel). 2021 Apr 28;13(9):2123. doi: 10.3390/cancers13092123.
6
Genome-wide DNA methylation and RNA expression differences correlate with invasiveness in melanoma cell lines.全基因组DNA甲基化和RNA表达差异与黑色素瘤细胞系的侵袭性相关。
Epigenomics. 2021 Apr;13(8):577-598. doi: 10.2217/epi-2020-0440. Epub 2021 Mar 30.
7
Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK.多种机制激活黑色素瘤中的 PI 3-激酶/mTOR 通路:PI 3-激酶抑制剂克服 BRAF 和 MEK 抑制剂耐药性的意义。
BMC Cancer. 2021 Feb 6;21(1):136. doi: 10.1186/s12885-021-07826-4.
8
Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.细胞重编程——黑色素瘤细胞可塑性模型
Int J Mol Sci. 2020 Nov 5;21(21):8274. doi: 10.3390/ijms21218274.
9
Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor‒Resistant Melanoma.非规范 EphA2 信号是 BRAF 抑制剂耐药性黑色素瘤中肿瘤内皮细胞相互作用和转移扩散的驱动因素。
J Invest Dermatol. 2021 Apr;141(4):840-851.e4. doi: 10.1016/j.jid.2020.08.012. Epub 2020 Sep 2.
10
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma.新西兰黑色素瘤细胞系 NZM 面板的基因组和信号通路特征:研究黑色素瘤遗传多样性影响的有价值模型。
Pigment Cell Melanoma Res. 2021 Jan;34(1):136-143. doi: 10.1111/pcmr.12908. Epub 2020 Jul 4.